Relapsing Remitting Multiple Sclerosis (RRMS) Pipeline Review, H2 2012 New Report
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Relapsing Remitting Multiple Sclerosis (RRMS), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Relapsing Remitting Multiple Sclerosis (RRMS).
View full press release